Consun Pharmaceutical (HKG:1681) said its board has proposed adopting a new share award scheme to strengthen employee incentives and support long-term growth, according to a Thursday Hong Kong bourse filing.

Shares of the company fell 2% in late morning trade Friday.

The proposed scheme will enable Consun to grant share awards to employees, service providers, and related participants as part of a broader performance-based incentive framework.

It carries a mandate limit of 84.3 million shares, representing about 9.9% of the company's issued share capital, along with a service provider sublimit of 8.4 million shares, or about 1%, the filing said.

The plan, approved by the board on Nov. 6, will be put to shareholders for approval at an extraordinary general meeting.